Skip to main content

The neural mechanism and pathways underlying postoperative nausea and vomiting: a comprehensive review

Abstract

This scoping review aims to synthesize evidence regarding the neural mechanisms and pathways underlying postoperative nausea and vomiting (PONV). We systematically searched the PubMed, Embase and Cochrane Library databases up to 2024. The findings indicate that PONV is a common complications after surgeries involving anaesthesia and can also lead to severe postoperative discomfort. Various surgical procedures and anaesthesia methods can trigger PONV, and the underlying neural mechanisms and signalling pathways are complex. It is currently assumed that these pathways do not exist independently of each other but that a central mode generator encompasses all relevant neurons and conducting nerve fibres, including the nucleus of the solitary tract, the dorsal nucleus of the tenth nerve, the area of the nerve, etc. After the information is integrated, it is transferred to the digestive tract, thereby causing PONV. In this article, we discuss the progress of research on the factors that influence PONV and identify the underlying pathways.

Background

Postoperative nausea and vomiting (PONV), which is one of the most common complications and side effects after surgeries involving anaesthesia, refers to nausea and vomiting symptoms that occur within 24–48 h after surgeries involving anaesthesia. PONV has a high incidence between 2 and 6 h postoperation. The prevalence of nausea and vomiting is ~ 20–30%, and in patients with high-risk factors, the prevalence is as high as 56–92% and the incidence is as high as 30–56%. PONV can cause physical and mental discomfort, delayed recovery and prolonged hospital stays; thus, nausea and vomiting are among the focuses of research on rapid rehabilitation surgery [1]. Nausea and vomiting are also major causes of rapid rehabilitation surgery (RRS) [2]; they also increase healthcare costs and lead to a decrease in patient satisfaction. The study revealed that annual medical expenditures for the treatment of postoperative nausea and vomiting in the United States increased by $253,270 to $519,617 [1]. Currently, most studies generally assume that the independent risk factors for PONV are as follows: female sex, laparoscopic surgery, a history of PONV, a history of motion sickness, inhalation anaesthetics, and the use of opioids [3]. However, there are many other risk factors for PONV, including the neural mechanisms underlying its occurrence. Therefore, there is no consensus regarding its prevention.

The physiological process of nausea and vomiting

Overview of nausea and vomiting

Nausea is a common clinical symptom that is a common precursor symptom of vomiting. However, in some cases, vomiting is not preceded by nausea. The onset of nausea is mediated by a complex reflex that, owing to the coordination of various muscles, causes discomfort and tightness in the epigastric region, which then leads to dry heaving or vomiting [4]. When the body responds to vomiting but has not yet excreted the stomach contents, the diaphragm and abdominal muscles contract and relax at the same time, the bottom of the stomach relaxes, and the intestines undergo strong retrograde contraction, which is also a form of routine gastric contraction. Intestinal reactions occur before vomiting. Sometimes, the final event is not expelling stomach contents, which is called dry heaving.

The vomiting response is commonly understood to involve expelling the contents of the stomach through the oesophagus and mouth. Vomiting occurs after nausea and is actually a protective reflex of the body. The vomiting process depends on the coordinated and continuous contraction of many smooth and somatic muscles. For example, the contraction of the abdominal muscles during vomiting is significantly longer than that of the diaphragm. The contraction time is greatly increased so that the stomach contents can pass through the diaphragm segment more easily. Vomiting can be divided into reflex vomiting (in which the body expels harmful substances from the body through vomiting), central vomiting (associated with certain diseases, such as meningitis), and vestibular disorder vomiting (caused by dysfunction of the vestibular system and sensory organ that influence the body's perception of spatial orientation and balance).

The factors influencing postoperative nausea and vomiting

Anaesthetic drug effects

Many different types of anaesthetics are commonly used in modern anaesthesia, such as inhalational anaesthetics (e.g., sevoflurane and isoflurane), sedatives, and opioid analgesics (e.g., sufentanil, fentanyl, and pethidine). Anaesthesia is considered one of the main triggers of PONV [5]. Many studies have shown that anaesthetics can cause nausea and vomiting when combined with certain protein targets. In addition, the mechanism of PONV may be related to the stimulation of the vomiting centre in the brainstem, which receives certain vomiting signals from the body. In this context, the use of anti-nausea and vomiting medications, such as ondansetron, granisetron (5-HT3 receptor antagonist), and colestipol, represents a breakthrough [6]. The use of ERAS also represents a breakthrough in this field. Owing to the implementation of ERAS at both the international and national levels, PONV has currently reached the same level as postoperative pain and requires special attention from anaesthesiologists. Therefore, new drugs and anaesthesia aids will be available now, thereby reducing the incidence of PONV, promoting the use of ERAS in surgical patients [7], increasing the turnover rate of patients in wards, reducing the hospital costs for each patient and enhancing patient comfort. Remimazolam, which is a new anaesthetic that is similar to midazolam, can bind to benzodiazepine receptors to form GABA–benzodiazepine complexes, thereby reducing dopamine activity and the release of 5-HT3. These sequelae lead to a reduction in dopamine intake or adenosine intake in the medullary vomiting centre, in turn causing a reduction in adenosine-mediated synthesis as well as the release and synthesis of adenosine in the CTZ, which is located in the last region of the fourth ventricle. Adenosine-mediated synthesis, release and postsynaptic dopamine receptor activity in the terminal zone of the fourth ventricle are reduced [8, 9]. Therefore, increased use of Rima during the induction of anaesthesia may reduce the incidence of PONV. Rima reduces the use of sevoflurane, an inhalation anaesthetic; furthermore, Rima also reduced the nonhepatic and renal metabolism and half-life of sevoflurane [10]. Studies have shown that the use of 0.20–0.25 mg/kg remimazolam during anaesthesia induction can significantly reduce the incidence of PONV in surgical patients within 2–6 h after surgery.

Gender and age

Most research shows that women and young patients are more susceptible to PONV. Some studies have shown that patients older than 50 years have a much lower risk of PONV than younger patients [11]. Experimental data have shown that women have a much greater risk of developing PONV than men, even when the same type of surgery, the same method of anaesthesia induction, and the same anaesthesia management method are used; this sex difference is partially due to variance in estrin values [12]. Therefore, it is recommended that male patients can usually be examined without PONV prophylaxis, whereas female patients should generally be routinely administered prophylaxis before and during surgery, taking blood volume into account [13]. For example, severe hypotension usually occurs during a caesarean section, resulting in a significant reduction in visceral blood flow and the release of vomiting factors in the gastrointestinal tract, resulting in PONV [14]. Therefore, attention must be devoted to the patient’s blood volume, and crystalloid or colloid fluids must be supplemented accordingly before and during surgery. In addition, Stefanie Klenke demonstrated that genetic factors influence this risk of PONV. The polymorphism of the CHRM3 rs2165870 and KCNB2 rs349358 SNPs has a significant impact on the incidence of PONV; however, this result lacks relevant evidence in the flying white population [15].

Type of surgery

Some types of surgical procedures (e.g., laparoscopic surgery, especially weight loss surgery and breast surgery) are more likely to trigger PONV. This association may be related to the surgical site and size of the surgery. For example, the incidence of PONV is much greater in laparoscopic gynaecological procedures than in laparoscopic gastrointestinal procedures [16]. In particular, since gastrointestinal surgeries themselves stimulate the gastrointestinal tract, most gastrointestinal surgeries affect the tenth abdominal nerve, which is one of the most important peripheral afferent pathways for triggering PONV. Such surgeries can affect PONV through peripheral pathways and affect gastrointestinal motility [17]. When nausea occurs, the normal function of the stomach changes. Therefore, we speculate that altered gastrointestinal motility after stomach and small intestine surgical procedures could be the cause of nausea in these patients.

History of preoperative vomiting and movement disorders

Patients with a history of preoperative vomiting or movement disorders are more likely to experience PONV. This is relatively easy to understand, similar to genetic history, family history, etc. Patients who are more sensitive to nausea and vomiting are more likely to experience PONV.

Bowel obstruction and gastrointestinal dysfunction

Intestinal obstruction or premature feeding and drinking can easily cause food or liquid to accumulate in the delicate intestine, thus preventing the intestine from moving normally and increasing the risk of PONV. Especially after various types of operations, patients experience insufficient intake of potassium, sodium, chlorine, etc. Due to long-term abstinence from alcohol and fasting, electrolyte imbalances occur, which lead to PONV.

Postoperative pain

Postoperative pain can cause hypotension and hypoxia, which can lead to the onset of nausea and vomiting. Similarly, patients with supine hypotension syndrome after anaesthesia induction during a caesarean section may experience severe nausea and vomiting. In particular, if the surgical method is open abdominal surgery, the patient will experience more pain as the size of the wound increases. A higher postoperative pain score also leads to a greater risk of developing PONV [18]. Therefore, patients receive more opioids for pain relief after surgery. However, the opioid dose is strongly correlated with the incidence of PONV [12]. The risk of PONV decreases when the dose of opioids is reduced by half.

Nausea- and vomiting-related scores

Since the risk of PONV is different for each patient, we can use PONV risk assessment to evaluate patients before and after surgery, thus applying individual anaesthesia methods and surgical methods to reduce postoperative complications. One commonly used evaluation method is the simplified Apfel scoring system [1, 19], which has four evaluation indicators, as shown in Table 1. This evaluation method varies greatly in actual application, so it is not a very accurate tool for stratifying PONV risk. However, this tool is based on patient data from outpatient surgeries and is, therefore, not suitable for inpatients.

Table 1 Apfel scoring system

The neural pathway mechanism of postoperative nausea and vomiting

It is generally accepted that all types of nausea and vomiting centres are located in the medulla oblongata of the brain and are composed of a series of interconnected exodus neurons. Furthermore, there is no isolated vomiting centre; rather, the various neurons are the neurons that are associated with the vomiting centre and that are loosely distributed in the medulla oblongata. When nausea and vomiting occur, the corresponding neurons are activated one after the other to be integrated into a central pattern generator (CPG). The medulla oblongata of the brain has two distinct functional areas in response to vomiting: the nerve reflex centre and the chemical receptor trigger zone. Impulses from the chemical receptor trigger zone are also transmitted to the former for reception and processing [20]. Therefore, the vomiting reflex can consist of three parts: the receptor, central integration and motor efference, which are generally similar to the reflective arc. The reflex arc consists of receptors (e.g., gastrointestinal chemoreceptors), afferent nerves, central nuclei (e.g., the nucleus tractus solitarius and parabrachial nucleus), efferent nerves, and effectors (e.g., the diaphragm and abdominal muscles). Vomiting requires coordinated activation of this pathway [21]. To put it simply, nausea and vomiting are also part of a special reflex arc.

Most nausea and vomiting symptoms are transmitted via the abovementioned route to the vestibular system and to the solitary nucleus before the route of transmission is reached.

Receptors and afferent nerves

As shown in Fig. 1, factors such as emetic agents in the blood and intestinal lumen contents and the gastric tone act can stimulate the corresponding receptor to complete the first step in the onset of nausea and vomiting. However, different stimulating factors are also uploaded via different routes. The afferent vagus nerve of the abdomen is a mechanical stimulation receptor that primarily senses the vomiting stimulus [22]. If there is a pulling stimulus in the gastrointestinal tract, the tenth nerve will capture it sharply and forwards it upwards. As chemical stimulus receptors, chemically sensitive receptors primarily perceive various irritating factors in the blood and in the digestive tract as well as some substances that are harmful to the organism.

Fig. 1
figure 1

Neurological reflex pathways of nausea and vomiting

The vestibular system consists of the brain centre (in the brainstem) and the external vestibular organs (in the ear). The peripheral vestibular apparatus consists of the external, superior and posterior semicircular canals; the ellipsoid capsule; and the bulb capsule. As a functional organ for maintaining balance, the peripheral vestibular receptor can receive motion-related sensory inputs from the vestibule of the inner ear and sense the body as well as body movements and head position to maintain body balance [23]. Studies have shown that changes in head and body alignment can impact the autonomic nervous system via the vestibular system. For example, head rotation can stimulate the nucleus solitarius and the cephalic ventral medullary reticular system, which is caused by the downwards action of the autonomic brainstem nerves. In addition, nausea and vomiting caused by motion sickness are strongly related to the vestibular system [24]. In other words, the vestibular organs are generally considered receptors for vomiting caused by exercise.

Gastrointestinal vagal afferent fibres: gastrointestinal vagal afferent fibres can dominate the stomach and intestines, such as the release of 5-hydroxytryptamine from intestinal endocrine cells that sense circulating drugs or local toxins in the gastrointestinal tract. When the stomach lining is irritated or damaged, enterochromaffin cells in the intestine can be stimulated to release substances, such as 5-HT or neurotransmitters. Most of them are projected onto a single core. The relevant receptors of the tenth gastrointestinal nerve in the fibres are combined with neurotransmitters to transmit the signal to the dorsal brainstem, with some signals projecting to the posterior zone, causing nausea and vomiting [25].

The last zone (postrema) is located at the floor of the fourth ventricle, on the back of the medulla oblongata and above the solitary bundle nucleus. The final area includes the vomiting reflex centre and the chemoreceptor trigger zone (CTZ); together with the medulla oblongata and vomiting centre, these regions are involved in the control of nausea and vomiting, thus causing central vomiting. Since this area does not have good protection from the blood‒brain barrier, some scientists even consider that it lacks a blood‒brain barrier, thus increasing the vulnerability of local neurons and glial cells to various chemical stimuli, such as gastrin and angiotensin. At this point, intractable belching, nausea, vomiting and other digestive symptoms may occur [26]. Therefore, this phenomenon is called medulla oblongata syndrome by some, in which the above clinical manifestations usually appear as the first symptom.

The cerebral cortex, thalamus and hypothalamus: activation of the cerebral cortex and the thalamic and hypothalamic regions triggers mental vomiting as well as vomiting induced by visual or olfactory stimulation [27]. When some patients are in a state of stress, fear or anxiety, or suffering from tremendous psychological and mental stimulation, the sensory organs transmit this information to the cerebral cortex, and through stimulation of the cerebral cortex, the information is transmitted to the medulla vomiting centre, which triggers vomiting.

Nerve centre

The nerve centre, which is also known as the vomiting centre in the reflex arc, includes the nucleus of the solitary tract, the dorsal nucleus of the tenth nerve, the area of the nerve, etc. [27]. The various signals uploaded to the centre are output to the effector after integration and adaptation, causing the body to trigger the corresponding activities.

Efferent nerves and effectors

When the nerve centre has finished integrating various sensory stimuli, the vomiting signal is transmitted downwards. The effector, i.e., our digestive system, receives the signal from the transmitted nerves and produces a neuromuscular response that results in extreme relaxation of the stomach. The intestines then experience a tremendous retrograde contraction that produces rhythmic movement in the gastrointestinal tract, while the posterior abdominal muscles continue to contract strongly. The cardia expands, and the involuntary inhalation of the body close the anorexia. At this point, the vomiting precursors have occurred, thus leading to vomiting. However, some stimuli continue to act only in the vomiting centre, leading to nausea or increased oral secretions.

Hierarchical integration of PONV pathways

Peripheral triggers: vagal afferents, gut enterochromaffin cells, and 5-HT3 receptor signalling.

Central integration: nucleus tractus solitarius (NTS) → parabrachial nucleus (PBN) → insular cortex connectivity.

Efferent output: dorsal motor nucleus of the vagus (DMV) and retrograde giant contraction (RGC) coordination.

Treatment of postoperative nausea and vomiting

Use of anti-nausea and vomiting medications

When identifying appropriate anti-nausea and vomiting medications, it is important to consider a patient's sufficient blood volume [28]. However, antiemetics may cause dizziness, headache, constipation, sedation, sleepiness, and additional severe reactions. When PONV occurs, targeted medications, such as 5-HT receptor antagonists and dopamine D2 receptor antagonists, can be used for treatment. Ondansetron is the most commonly studied 5-HT receptor antagonist, and experimental data have shown that ondansetron is more effective than metoclopramide and dexmedetomidine. Furthermore, the incidence of PONV is lower among patients who take granisetron than among patients who take ondansetron. However, its use of granisetron requires comprehensive consideration of various factors, such as the patient’s economic situation. In addition, the use of hormonal drugs has gradually increased. For example, intravenous injection of 8 to 10 mg dexamethasone during the induction of general anaesthesia can reduce PONV within 24 h. Some studies have reported that high-dose corticosteroids (> 15 mg) are more effective than low-dose corticosteroids [29]. Dexamethasone can reduce the need for rescue antiemetics for up to 72 h. However, it is also important to be aware of the side effects of these medications, the vast majority of which are negligible at PONV doses. There are many complications associated with dexamethasone, such as increased risks of infection, delayed wound healing and hyperglycaemia and related complications. Therefore, the side effects of dexamethasone should not be underestimated. 5-HT receptor blockers can prolong the QT interval and exert negative effects on the cardiovascular system, thus increasing the risk of malignant cardiac arrhythmias and sudden cardiac death in patients; furthermore, repeated administration of these agents may lead to receptor tachyphylaxis, thus diminishing efficacy in chronic settings [30]. At present, many new drugs and compound preparations are being examined in clinical trials. Among them, the natorpitam‒palonostron compound preparation (NK1/5-HT3 double antagonism) has exhibited a 24-h PONV control rate of 85%. As a 5-HT3/D2 receptor double antagonist, olanzapine can be used as an anti-PONV agent [31]. In summary, when anti-vomiting medications are used, it is best to use different medications depending on a patient’s individual risk factors. However, there is no research on which combination of prevention measures can achieve the best results, and further research is needed [32].

Nonpharmacological strategies

Aromatherapy

Aromatherapy is a complementary therapeutic approach that uses volatile plant extracts (essential oils) to promote physiological and psychological well-being. Postoperative nausea and vomiting (PONV) management primarily involves the inhalation of essential oils (e.g., peppermint, ginger [33], or isopropyl alcohol) [34] to modulate the olfactory system and gastrointestinal neural pathways. Aromatherapy has emerged as a nonpharmacological adjunct for PONV. The inhalation of essential oils (e.g., peppermint or ginger) may modulate nausea through two pathways: (1) direct olfactory stimulation, which suppresses the vomiting centre in the medulla and (2) local absorption of active compounds (e.g., menthol), which act on gastric 5-HT3 receptors [33]. While Cochrane reviews have reported only modest evidence regarding the efficacy of aromatherapy [31], its low cost and safety profile justify its clinical consideration.

Hydration

Hydration in the perioperative context refers to the strategic administration of intravenous or oral fluids to maintain physiological fluid balance [35], optimize tissue perfusion, and prevent hypovolemia. Adequate hydration has been shown to be associated with a reduced risk of PONV, and the underlying mechanism likely involves stabilizing haemodynamics and minimizing gastrointestinal hypoperfusion-induced nausea [1].

Perioperative hydration plays a critical role in preventing PONV. Hypovolemia-induced splanchnic vasoconstriction may trigger nausea via gut ischaemia and serotonin release. Current guidelines recommend balanced crystalloid administration (20–30 mL/kg) to maintain adequate perfusion, although excessive fluids should be avoided due to pulmonary complications [1]. Meta-analyses suggest that this approach reduces the incidence of PONV by 20–30% [35].

Acupressure and acupuncture

Noninvasive acupressure at the PC6 (Neiguan) point has been shown to effectively reduce the incidence of PONV by ~ 30% [36], comparable to first-line antiemetics, such as ondansetron. The mechanism underlying this effect may involve vagal modulation and endogenous opioid release, which suppress the chemoreceptor trigger zone in the area postrema. In contrast, traditional acupuncture requires trained practitioners to insert needles at specific sites (e.g., PC6 and ST36), potentially enhancing effects through sustained neurohumoural regulation [37]. Despite heterogeneity in trial protocols, recent meta-analyses support the adjunctive roles of acupressure and acupuncture, particularly in high-risk patients [1].

Lifestyle and dietary factors

Emerging evidence has revealed the role of preoperative behavioural interventions in preventing PONV. Anxiety reduction via guided imagery or medication (e.g., benzodiazepines) may suppress HPA axis hyperactivity, thereby decreasing stress-induced nausea [37]. Smokers exhibit a lower incidence of PONV, possibly because of the antidopaminergic effects of nicotine; however, smoking should not be encouraged [5]. Dietary strategies for preventing PONV include oral intake of 1–2 g of ginger preoperatively, which inhibits prostaglandin synthesis and gut serotonin release [38, 39].

Carbohydrate-rich clear liquids can also be administered up to 2 h before surgery to maintain gastric motility and reduce fasting-induced discomfort [40].

Postoperative intake of irritants such as fatty/spicy foods may exacerbate nausea via vagal irritation [37].

Comparative efficacy of PONV prevention strategies

Effective prevention of postoperative nausea and vomiting (PONV) relies on risk stratification and multimodal approaches. Key strategies include:

Pharmacologic agents

5-HT3 antagonists (e.g., ondansetron): first-line for early PONV, minimal sedation. Dexamethasone: enhances efficacy when combined with 5-HT3 antagonists, effective for delayed PONV. NK1 antagonists (e.g., aprepitant): superior for delayed symptoms but higher cost. Dopamine antagonists (e.g., droperidol): effective but limited by sedation/extrapyramidal risks.

Non-pharmacologic methods

Acupuncture/acupressure (e.g., P6 stimulation): mild efficacy, suitable as adjunct therapy. Combination therapy: multimodal regimens (e.g., 5-HT3 antagonist + dexamethasone) demonstrate synergistic effects, reducing PONV incidence by 50–80% in high-risk patients versus monotherapy. Risk-based tailoring: guidelines recommend ≥ 2 interventions for moderate/high-risk patients. Emerging evidence supports aprepitant or low-dose naloxone for refractory cases.

Overall, a patient-specific approach balancing efficacy, safety, and cost optimizes outcomes (Table 2).

Table 2 Comparative efficacy of PONV prevention strategies [1, 33, 41]

Future directions

While current therapies mitigate the risk of PONV in many patients, critical gaps in knowledge remain. First, GWAS cohorts are urgently needed to map genetic variants (e.g., 5-HT3R SNPs) linked to PONV susceptibility and drug resistance [42]. Second, AI models that integrate real-time EEG entropy and surgical stress biomarkers could enable dynamic risk prediction [43].

Summary

PONV is a common complication that occurs after surgeries involving anaesthesia. PONV affects postoperative recovery and quality of life. This in-depth study of the underlying aetiology, neural mechanisms and pathways of PONV has important reference value for clinicians and can help to reduce the incidence of PONV. Although existing research results and guidelines offer numerous prevention and treatment methods, their practical application is often limited by individual differences and differences in the types of surgery. There have been no significant advances in knowledge on the neurological mechanisms and pathways underlying PONV, thus limiting the development of preventive strategies. Therefore, patients may still experience varying degrees of nausea and vomiting. Future research should further clarify the neural pathways involved in PONV to formulate more effective preventive measures, thereby reducing the occurrence of PONV in the clinic and improving patients’ treatment experience.

Availability of data and materials

No datasets were generated or analysed during the current study.

Abbreviations

PONV:

Postoperative nausea and vomiting

ERAS:

Rapid rehabilitation surgery

5-HT3:

5-Hydroxytryptamine type 3 receptor

CTZ:

Chemoreceptor Trigger Zone

NTS:

Nucleus tractus solitarius

PBN:

Parabrachial nucleus

DMV:

Dorsal motor nucleus of the vagus

RGC:

Retrograde giant contraction

References

  1. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131:411–48.

    Article  PubMed  Google Scholar 

  2. Moningi S, Patki A, Padhy N, Ramachandran G. Enhanced recovery after surgery: an anesthesiologist’s perspective. J Anaesthesiol Clin Pharmacol. 2019;35:S5-13.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Squire Y, Spencer R. Postoperative nausea and vomiting. Anaesth Intensive Care Med. 2018;19:475–9.

    Article  Google Scholar 

  4. Veiga-Gil L, Pueyo J, López-Olaondo L. Postoperative nausea and vomiting: physiopathology, risk factors, prophylaxis and treatment. Rev Esp Anestesiol Reanim (Engl Ed). 2017;64:223–32.

    Article  CAS  Google Scholar 

  5. Horn CC, Wallisch WJ, Homanics GE, Williams JP. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol. 2014;722:55–66.

    Article  CAS  PubMed  Google Scholar 

  6. Yadav G, Pratihary BN, Jain G, Paswan AK, Mishra LD. A prospective, randomized, double blind and placebo-control study comparing the additive effect of oral midazolam and clonidine for postoperative nausea and vomiting prophylaxis in granisetron premedicated patients undergoing laparoscopic cholecystecomy. J Anaesthesiol Clin Pharmacol. 2013;29:61–5.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Echeverria-Villalobos M, Stoicea N, Todeschini AB, Fiorda-Diaz J, Uribe AA, Weaver T, et al. Enhanced recovery after surgery (ERAS): a perspective review of postoperative pain management under ERAS pathways and its role on opioid crisis in the United States. Clin J Pain. 2020;36:219–26.

    Article  PubMed  Google Scholar 

  8. Hartgraves PM, Primosch RE. An evaluation of oral and nasal midazolam for pediatric dental sedation. ASDC J Dent Child. 1994;61:175–81.

    CAS  PubMed  Google Scholar 

  9. Reitan JA, Porter W, Braunstein M. Comparison of psychomotor skills and amnesia after induction of anesthesia with midazolam or thiopental. Anesth Analg. 1986;65:933–7.

    Article  CAS  PubMed  Google Scholar 

  10. Choi JY, Lee HS, Kim JY, Han DW, Yang JY, Kim MJ, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: a randomized non-inferiority trial. J Clin Anesth. 2022;82: 110955.

    Article  CAS  PubMed  Google Scholar 

  11. Tateosian VS, Champagne K, Gan TJ. What is new in the battle against postoperative nausea and vomiting? Best Pract Res Clin Anaesthesiol. 2018;32:137–48.

    Article  PubMed  Google Scholar 

  12. Stoops S, Kovac A. New insights into the pathophysiology and risk factors for PONV. Best Pract Res Clin Anaesthesiol. 2020;34:667–79.

    Article  PubMed  Google Scholar 

  13. Haentjens LL, Ghoundiwal D, Touhiri K, Renard M, Engelman E, Anaf V, et al. Does infusion of colloid influence the occurrence of postoperative nausea and vomiting after elective surgery in women? Anesth Analg. 2009;108:1788–93.

    Article  PubMed  Google Scholar 

  14. Tan HS, Habib AS. The optimum management of nausea and vomiting during and after cesarean delivery. Best Pract Res Clin Anaesthesiol. 2020;34:735–47.

    Article  PubMed  Google Scholar 

  15. Klenke S, Frey UH. Genetic variability in postoperative nausea and vomiting: a systematic review. Eur J Anaesthesiol. 2020;37:959–68.

    Article  PubMed  Google Scholar 

  16. Parisi A, Desiderio J, Cirocchi R, Trastulli S. Enhanced recovery after surgery (ERAS): a systematic review of randomised controlled trials (RCTs) in bariatric surgery. Obes Surg. 2020;30:5071–85.

    Article  PubMed  Google Scholar 

  17. Halliday TA, Sundqvist J, Hultin M, Walldén J. Post-operative nausea and vomiting in bariatric surgery patients: an observational study. Acta Anaesthesiol Scand. 2017;61:471–9.

    Article  CAS  PubMed  Google Scholar 

  18. Rajan N, Joshi GP. Management of postoperative nausea and vomiting in adults: current controversies. Curr Opin Anaesthesiol. 2021;34:695–702.

    Article  PubMed  Google Scholar 

  19. Massoth C, Schwellenbach J, Saadat-Gilani K, Weiss R, Pöpping D, Küllmar M, et al. Impact of opioid-free anaesthesia on postoperative nausea, vomiting and pain after gynaecological laparoscopy—a randomised controlled trial. J Clin Anesth. 2021;75: 110437.

    Article  CAS  PubMed  Google Scholar 

  20. Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111:106–12.

    Article  Google Scholar 

  21. Becker DE. Nausea, vomiting, and hiccups: a review of mechanisms and treatment. Anesth Prog. 2010;57:150–7.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Horn CC. Why is the neurobiology of nausea and vomiting so important? Appetite. 2008;50:430–4.

    Article  PubMed  Google Scholar 

  23. Khan S, Chang R. Anatomy of the vestibular system: a review. NeuroRehabilitation. 2013;32:437–43.

    PubMed  Google Scholar 

  24. Joshi S, Shelar V. Presence of vestibular dysfunction in individuals with motion sickness. Physiother Rehabil. 2019;4:2573–82.

    Google Scholar 

  25. Bashashati M, McCallum RW. Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders. Eur J Pharmacol. 2014;722:79–94.

    Article  CAS  PubMed  Google Scholar 

  26. Deng B, Wang J, Yu H, Jin L, Qiu Y, Liu X, et al. Area postrema syndrome in autoimmune glial fibrillary acidic protein astrocytopathy: a case series and literature review. Neurol Neuroimmunol Neuroinflammation. 2022;9: e200029.

    Article  Google Scholar 

  27. Miller AD, Nonaka S, Jakusˇ J. Brain areas essential or non-essential for emesis. Brain Res. 1994;647:255–64.

    Article  CAS  PubMed  Google Scholar 

  28. Borgeat A, Ekatodramis G, Schenker CA. Postoperative nausea and vomiting in regional anesthesia: a review. Anesthesiology. 2003;98:530–47.

    Article  PubMed  Google Scholar 

  29. Lex JR, Edwards TC, Packer TW, Jones GG, Ravi B. Perioperative systemic dexamethasone reduces length of stay in total joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2021;36:1168–86.

    Article  PubMed  Google Scholar 

  30. Fugetto F, Filice E, Biagi C, Pierantoni L, Gori D, Lanari M. Single-dose of ondansetron for vomiting in children and adolescents with acute gastroenteritis—an updated systematic review and meta-analysis. Eur J Pediatr. 2020;179:1007–16.

    Article  PubMed  Google Scholar 

  31. Nasir SS, Schwartzberg LS. Recent advances in preventing chemotherapy-induced nausea and vomiting. Oncology (Williston Park). 2016;30:750–62.

    PubMed  Google Scholar 

  32. Hirai S, Ida M, Kawaguchi M. Comparison of prophylaxis strategy for postoperative nausea and vomiting and its incidence before and after the implementation of 5-hydroxytryptamine 3 in surgical setting: a single-center, retrospective study. J Anesth. 2024;38:398–404.

    Article  PubMed  Google Scholar 

  33. Hines S, Steels E, Chang A, Gibbons K. Aromatherapy for treatment of postoperative nausea and vomiting. Cochrane Database Syst Rev. 2018;3: CD007598.

    PubMed  Google Scholar 

  34. Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47:738–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Marsh E, Millette D, Wolfe A. Complementary intervention in postoperative care: aromatherapy’s role in decreasing postoperative nausea and vomiting. J Holist Nurs. 2022;40:351–8.

    Article  PubMed  Google Scholar 

  36. Jewer JK, Wong MJ, Bird SJ, Habib AS, Parker R, George RB. Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting. Cochrane Database Syst Rev. 2019;3: CD012212.

    PubMed  Google Scholar 

  37. Lee A, Chan SKC, Fan LTY. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015;2015: CD003281.

    PubMed  PubMed Central  Google Scholar 

  38. Yoo SS, Teh EK, Blinder RA, Jolesz FA. Modulation of cerebellar activities by acupuncture stimulation: evidence from fMRI study. Neuroimage. 2004;22:932–40.

    Article  PubMed  Google Scholar 

  39. Wang SM, Kain ZN. Preoperative anxiety and postoperative nausea and vomiting in children: is there an association? Anesth Analg. 2000;90:571–5.

    Article  CAS  PubMed  Google Scholar 

  40. Joshi GP, Abdelmalak BB, Weigel WA, Harbell MW, Kuo CI, Soriano SG, et al. 2023 American Society of Anesthesiologists practice guidelines for preoperative fasting: carbohydrate-containing clear liquids with or without protein, chewing gum, and pediatric fasting duration—a modular update of the 2017 American Society of Anesthesiologists practice guidelines for preoperative fasting. Anesthesiology. 2023;138:132–51.

    Article  PubMed  Google Scholar 

  41. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000;84:367–71.

    Article  CAS  PubMed  Google Scholar 

  42. Theodosopoulou P, Rekatsina M, Staikou C. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics. Minerva Anestesiol. 2023;89:565–76.

    Article  PubMed  Google Scholar 

  43. Zhou CM, Wang Y, Xue Q, Yang JJ, Zhu Y. Predicting early postoperative PONV using multiple machine-learning- and deep-learning-algorithms. BMC Med Res Methodol. 2023;23:133.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors extend their appreciation to Springer Nature Author Services for their meticulous language editing and constructive suggestions on the manuscript.

Funding

This work was supported by the Guizhou High-Level Innovative Talent “Thousand-Level” Training Program (Grant No. GZSYQCC [2023] 006).

Author information

Authors and Affiliations

Authors

Contributions

ZZ collects data and writes the first draft. It is the main contributor to the manuscript. XW is responsible for researching concept generation, review and revision and fund acquisition. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Xin Wang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Z., Wang, X. The neural mechanism and pathways underlying postoperative nausea and vomiting: a comprehensive review. Eur J Med Res 30, 362 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40001-025-02632-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40001-025-02632-1

Keywords